X chromosome monosomy restricted to the left ventricle is not a major cause of isolated hypoplastic left heart

American Journal of Medical Genetics, Part A

Volumn 152, Issue 8, 2010, Pages 1967-1972

  Bernardini, Laura ^a   Giuffrida, Maria Grazia ^a   Francalanci, Paola ^b   Capalbo, Anna ^a   Novelli, Antonio ^a   Callea, Francesco ^b   Dallapiccola, Bruno ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Hypoplastic left heart sequence (HLHS); Interphase FISH analysis; Monosomy X; Mosaic; Somatic mutation

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ADOLESCENT; ANEUPLOIDY; ARTICLE; CENTROMERE; CHILD; CHROMOSOME MOSAICISM; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPLASTIC LEFT HEART SYNDROME; INCIDENCE; INFANT; MALE; MONOSOMY X; NEWBORN; PRIORITY JOURNAL; RELIABILITY;

CHROMOSOMES, HUMAN, X; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; MALE; MONOSOMY;

EID: 77955297556     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33538     Document Type: Article

References (35)

1. Andelfinger G. 2008. Genetic factors in congenital heart malformation. Clin Genet 73:516-527.
2. Boué J, Bou A, Lazar P. 1975. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneoushumanabortions. Teratology 12:11-26.
3. Brackley KJ, Kilby MD, Wright JG, Brawn WJ, Sethia B, Stumper O, Holder R, Wyldes MP, Whittle MJ. 2000. Outcome after prenatal diagnosis of hypoplastic left-heart syndrome: A case series. Lancet 356:1143-1147.
4. Connor JA, Thiagarajan R. 2007. Hypoplastic left heart syndrome. Orphanet J Rare Dis 2:23.
5. deAlmeida A, McQuinn T, Sedmera D. 2007. Increased ventricular preload is compensated by myocyte proliferation in normal and hypoplastic fetal chick left ventricle. Circ Res 100:1363-1370.
6. Draus JM Jr, Hauck MA, Goetsch M, Austin EH III, Tomita-Mitchell A, Mitchell ME. 2009. Investigation of somatic NKX 2-5 mutations in congenital heart disease. J Med Genet 46:115-122.
7. Elliott DA, Kirk EP, Yeoh T, Chandar S, McKenzie F, Taylor P, Grossfeld P, Fatkin D, Jones O, Hayes P, Feneley M, Harvey RP. 2003. Cardiac homeobox gene NKX 2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol 41:2072-2076.
8. Epstein CJ. 1986. The consequences of chromosome imbalance. Principles, mechanisms and models. Developmental and cell biology monographs n. 18. New York: Cambridge University Press.
9. Gambetta K, Al-Ahdab MK, Ilbawi MN, Hassaniya N, Gupta M. 2008. Transcription repression and blocks in cell cycle progression in hypoplastic left heart syndrome. Am J Physiol Heart Circ Physiol 294:H2268-H2275.
10. Gøtzsche CO, Krag-Olsen B, Nielsen J, Sørensen KE, Kristensen BO. 1994. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 71:433-436.
11. Grossfeld PD. 1999. The genetics of hypoplastic left heart syndrome. Cardiol Young 9:627-663.
12. Grossfeld PD. 2007. Hypoplastic left heart syndrome: It is all in the genes. J Am Coll Cardiol 50:1596-1597.
13. Grossfeld P, Ye M, Harvey R. 2009. Hypoplastic left heart syndrome: New genetic insights. J Am Coll Cardiol 53:1072-1074.
14. Haverkamp F, Wolfle J, Zerres K, Butebandt O, Amendt P, Hauffa BP, Weimann E, Bettendorf M, Keller E, Mühlenberg R, Partsch CJ, Sippel WG, Hoppe C. 1999. Growth retardation in Turner syndrome: Aneuploidy, rather than specific gene loss, may explain growth failure. J Clin Endocrinol Metab 84:4578-4582.
15. Keller B. 1995. Functional maturation and coupling of the embryonic cardiovascular system. In: Clark EB, Markwald RR, Takao A, eds. Developmental mechanisms of heart disease. Mt. Kisco, NY: Futura Publishing Co. p 367-396.
16. Loscalzo ML, Van PL, Ho VB, Bakalov VK, Rosing DR, Malone CA, Dietz HC, Bondy CA. 2005. Association between fetal lymphedema and congenital cardiovascular defects in Turner syndrome. Pediatrics 115:732-735.
17. Meilhac SM, Esner M, Kelly RG, Nicolas JF, Buckingham ME. 2004. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell 6:685-698.
18. Mogensen J, Arbustini E. 2009. Restrictive cardiomyopathy. Curr Opin Cardiol 24:214-220.
19. Morris CD, Outcalt J, Menashe VD. 1990. Hypoplastic left heart syndrome: Natural history in a geographically defined population. Pediatrics 85:977-983.
20. Olson EN. 2006. Gene regulatory networks in the evolution and development of the heart Science 313:1922-1927.
21. Reamon-Buettner SM, Borlak J. 2004.TBX5 mutations in non-Holt - Oram syndrome (HOS) malformed hearts. Hum Mutat 24:104.
22. Reamon-Buettner SM, Borlak J. 2005. GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart. J Med Genet 42:e32.
23. Reamon-Buettner SM, Borlak J. 2006a. Somatic mutations in cardiac malformations. J Med Genet 43:45.
24. Reamon-Buettner SM, Borlak J. 2006b. HEY2 mutations in malformed hearts. Hum Mutat 27:118.
25. Reamon-Buettner SM, Hecker H, Spanel-Borowski K, Craatz S, Kuenzel E, Borlak J. 2004. Novel NKX 2-5 mutations in diseased heart tissues of patients with cardiac malformations. Am J Pathol 164:2117-2125.
26. Reamon-Buettner SM, Cho SH, Borlak J. 2007. Mutations in the 3′-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD). BMC Med Genet 8:38.
27. Reamon-Buettner SM, Ciribilli Y, Inga A, Borlak J. 2008.Aloss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. Hum Mol Genet 17:1397-1405.
28. Reamon-Buettner SM, Ciribilli Y, Traverso I, Kuhls B, Inga A, Borlak J. 2009. A functional genetic study identifies HAND1 mutations in septation defects of the human heart. Hum Mol Genet 18:3567-3578.
29. Remstein ED, Kurtin PJ, Buño I, Bailey RJ, Proffitt J, Wyatt WA, Hanson CA, Dewald GW. 2000. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol 100:856-862.
30. Surerus E, Huggon IC, Allan LD. 2003. Turner's syndrome in fetal life. Ultrasound Obstet Gynecol 22:264-267.
31. Taylor MR, Carniel E, Mestroni L. 2006. Cardiomyopathy familial dilated. Orphanet J Rare Dis 1:27.
32. Tchervenkov CI, Jacobs JP, Weinberg PM, Aiello VD, Béland MJ, Colan SD, Elliott MJ, Franklin RC, Gaynor JW, Krogmann ON, Kurosawa H, Maruszewski B, Stellin G. 2006. The nomenclature, definition and classification of hypoplastic left heart syndrome. Cardiol Young 16:339-368.
33. Van Egmond H, Orye E, Praet M, Coppens M, Devloo-Blancquaert A. 1988. Hypoplastic left heart syndrome and 45, X karyotype. Br Heart J 60:69-71.
34. Ye M, Hamzeh R, Geddis A, Varki N, Perryman MB, Grossfeld P. 2009. Deletion of JAM-C, a candidate gene for heart defects in Jacobsen syndrome, results in a normal cardiac phenotype in mice. Am J Med Genet Part A 149A:1438-1443.
35. Yurov YB, Iourov IY, Vorsanova SG, Liehr T, Kolotii AD, Kutsev SI, Pellestor F, Beresheva AK, Demidova IA, Kravets VS, Monakhov VV, Soloviev IV. 2007. Aneuploidy and confined chromosomal mosaicism in the developing human brain. PloS One 2:e558.